Cover Image
Market Research Report

Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

Published by IMARC Services Pvt. Ltd. Product code 345916
Published Content info 90 Pages
Delivery time: 1-2 business days
Price
Back to Top
Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics
Published: April 29, 2017 Content info: 90 Pages
Description

Diabetes is rapidly gaining the status of a potential epidemic in India with around 65 million people currently being affected by it. The Indian population that had faced under nutrition for a long time is now exposed to over nutrition and sedentary lifestyles. Coupled with a bad nutritional history and the fact that Indians are genetically more vulnerable to diabetes compared to other population groups, India's struggle with diabetes is expected to be one of the biggest epidemics the country has ever witnessed.

India's diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in the healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.

IMARC's new report ‘"Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics"’ provides an analytical and statistical insight into the Indian diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral Antidiabetics, Insulin and Diabetes Diagnostics. For each of the aforementioned categories, the report provides historical and future market sales, performance of key classes and the performance of top players.

The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Indian diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian diabetes market in some form or the other.

What we have achieved in this report:

Comprehensive situation analysis of the Indian diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in India
  • Historical, current and future prevalence of type-1 and type-2 diabetes in India
  • Historical, current and future prevalence of diabetes in the urban and rural regions in India
  • Historical, current and future prevalence of diabetes among males and females in India
  • Historical, current and future prevalence of diabetes among various age groups in India
  • Historical, current and future diagnosis rates for diabetes in India
  • Historical, current and future drug treatment rates for diabetes in India

Comprehensive situation analysis of the Indian Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the Indian Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the diabetes diagnostics market and its dynamics:

Focus of the Analysis:

  • Performance of the diabetes diagnostics market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook
Table of Contents
Product Code: SR1018D28_Report

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Diabetes Disease Overview

  • 4.1. What is Diabetes?
  • 4.2. Diabetes Diagnosis and Treatment
    • 4.2.1. Diagnosis
    • 4.2.2. Treatment
  • 4.3. Diabetes Complications

5. Factors Driving the Diabetes Market in India

  • 5.1. Increasing Obesity Levels
  • 5.2. Urbanization
  • 5.3. India has the Second Largest Diabetes Patient Base in the World
  • 5.4. India Represents One of the Fastest Growing Markets Globally
  • 5.5. Improving Diagnosis and Treatment Rates

6. The Indian Diabetes Epidemiology

  • 6.1. Diabetes Population and Prevalence Rates
  • 6.2. Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
  • 6.3. Population and Prevalence Rates by Region (Urban and Rural)
  • 6.4. Population and Prevalence Rates by Gender
  • 6.5. Population and Prevalence Rates by Age Group
  • 6.6. Diabetes Diagnosis and Drug Treatment Rates

7. Indian Diabetes Market

  • 7.1. Historical Market Trends (2009-2016)
  • 7.2. Market Breakup by Segment (2009-2016)
  • 7.3. The Indian Oral Antidiabetics Market
    • 7.3.1. Historical Market Trends (2009-2016)
    • 7.3.2. Market Breakup by Class (2009-2016)
    • 7.3.3. Market Shares of Key Players
    • 7.3.4. Market Outlook (2017-2021)
  • 7.4. The Indian Insulin Market
    • 7.4.1. Historical Market Trends (2017-2021)
    • 7.4.2. Market Breakup by Class
    • 7.4.3. Market Shares of Key Players
    • 7.4.4. Market Outlook (2017-2021)
  • 7.5. Market Outlook (2017-2021)

8. Indian Diabetes Diagnostics Market

  • 8.1. Historical Market Trends (2009-2016)
  • 8.2. Market Segmentation
  • 8.3. Market Shares of Key Players
  • 8.4. Market Outlook (2017-2021)

9. SWOT Analysis

  • 9.1. Strengths
  • 9.2. Weaknesses
  • 9.3. Opportunities
  • 9.4. Threats

10. Value Chain Analysis

11. Porter's Five Forces

12. Competitive Structure

13. Key Player Profiles

  • 13.1. Abbott
  • 13.2. Sanofi
  • 13.3. Eli Lilly
  • 13.4. USV
  • 13.5. Sun Pharma

List of Figures

  • Figure 4-1: The Impact of Diabetes on the Human Body
  • Figure 4-2: Diabetes Complications
  • Figure 4-3: India: Overweight & Obese Population (in Millions), 2009, 2016 & 2021
  • Figure 5-2: Body Mass Index and Relative Risk of Type-2 Diabetes
  • Figure 5-3: Global: Breakup of Diabetes Patients by Region (in %), 2016 & 2021
  • Figure 6-1: India: Total Number of Diabetes Patients (in Millions), 2009-2016
  • Figure 6-2: India: Total Number of Diabetes Patients Forecast (in Millions), 2017-2021
  • Figure 6-3: India (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2009-2016
  • Figure 6-4: India (Type1 & Type2): Total Number of Diabetes Patients Forecast (in Millions) 2017-2021
  • Figure 6-5: India (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2009-2016
  • Figure 6-6: India (Urban & Rural): Total Number of Diabetes Patients Forecast (in Millions), 2017-2021
  • Figure 6-7: India (Male & Female): Total Number of Diabetes Patients (in Millions), 2009-2016
  • Figure 6-8: India (Male & Female): Total Number of Diabetes Patients Forecast (in Millions), 2017-2021
  • Figure 6-9: India: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 2009-2016
  • Figure 6-10: India: Total Number of Diabetes Patients by Age Group Forecast (20-39), (40-59) & (60-79) (in Millions), 2017-2021
  • Figure 6-11: India: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2009-2016
  • Figure 6-12: India: Total Diagnosed & Drug Treated Diabetes Population Forecast (in Millions), 2017-2021
  • Figure 7-1: India: Diabetes Market (in Million US$), 2009-2016
  • Figure 7-2: India: Diabetes Market: Share of Oral Antidiabetics and Insulin (in %), 2009-2016
  • Figure 7-3: India: Oral Antidiabetics Market (in Million US$), 2009-2016
  • Figure 7-4: India: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2009-2016
  • Figure 7-5: India: Oral Antidiabetics Market: Sales Share of Key Players (in %)
  • Figure 7-6: India: Oral Antidiabetics Market Forecast (in Million US$), 2017-2021
  • Figure 7-7: India: Oral Antidiabetics Market Forecast: Sales Share of Key Classes (in %), 2016 & 2020
  • Figure 7-8: India: Insulin Market (in Million US$), 2009-2016
  • Figure 7-9: India: Insulin Market: Sales Share of Key Classes (in %), 2016
  • Figure 7-10: India: Insulin Market: Sales Share of Key Players (in %)
  • Figure 7-11: India: Insulin Market Forecast (in Million US$), 2017-2021
  • Figure 7-12: India: Insulin Market Forecast: Sales Share of Key Classes (in %), 2016 & 2021
  • Figure 7-13: India: Diabetes Market Forecast (in Million US$), 2017-2021
  • Figure 7-14: India: Diabetes Market Forecast: Share of Oral Antidiabetics and Insulin (in %), 2017-2021
  • Figure 8-1: India: Glucose Monitoring Market (in Million US$), 2009-2016
  • Figure 8-2: India: Glucose Monitoring Market: Sales Share by Segment (in %),
  • Figure 8-3: India: Glucose Monitoring Market: Sales Share of Key Players (in %)
  • Figure 8-4: India: Glucose Monitoring Market Forecast (in Million US$), 2017-2021
  • Figure 9-1: Indian: Diabetes Market: SWOT Analysis
  • Figure 10-1: Indian: Diabetes Market: Value Chain Analysis
  • Figure 11-1: Indian: Diabetes Market: Porter's Five Forces Analysis

List of Tables

  • Table 2-1: India: Diabetes Epidemiology: Executive Summary
  • Table 2-2: India: Diabetes Market: Executive Summary
  • Table 3-1: Diagnosis of Diabetes
  • Table 4-1: India: Overweight & Obesity Statistics, 2005, 2010 & 2016
  • Table 4-2: India: Urban & Rural Population Breakup (in Millions), 1992, 2001, 2011
  • Table 4-3: Global: Diabetes Population Breakup by Country (in 000's), 2016 & 2021
  • Table 4-4: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets
  • Table 5-1: India: Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2021
  • Table 5-2: India (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2021
  • Table 5-3: India (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2021
  • Table 5-4: India (Male & Female): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2021
  • Table 5-5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2009, 2016 & 2021
  • Table 5-6: India: Total Diagnosed & Drug Treated Diabetes Population, 2009, 2016 & 2021
Back to Top